Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Clinical Microbiology & Infections

About Conference


Conference Series with immense pleasure invites all the contributors across the globe to the 8th Annual Congress on Clinical Microbiology conference (Annual Clinical Microbiology) during December 05-06, 2018 at Vancouver, Canada, focusing on the theme “Exploring Innovative Research in Clinical Microbiology” Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Conference Series organizes 1000+ scientific events inclusive of 600+ Conferences, 500+ Workshops and 200+ Symposiums on various topics of Science & Technology across the globe with support from 1000 more scientific societies and Publishes 500+ Open Access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

8th Annual Congress on Clinical Microbiology conference officially welcomes you to attend the two days of vigorous discussion conference for elaborating the present therapies and exploring new approaches. This gathering will affect an alluring minute to meet individuals in the exploration field and along these lines it takes a get a kick out of opening a door to meet the capacity in the field, youthful analysts and potential speakers.

Clinical microbiology is the study of prevention, diagnosis and treatment of infectious diseases.  Conference Series provides a vast platform for Clinical, Biotechnology, Pharmaceutical and healthcare. This will allow the researcher to present their research work through presentations and have a chance to gain more knowledge about the current situation related to clinical recognition at this 2-day event.

Why Vancouver, Canada:

We hope you will join us in Vancouver, Canada which is the third-largest metropolitan coastal seaport city in Canada, located in the Lower Mainland region of British Columbia. With its scenic views, mild climate, and friendly people, Vancouver is known around the world as both a popular tourist attraction and one of the best places to live.

The actual temperature of Vancouver, Canada in August is around 14-22°C. Vancouver is also one of the most ethnically and linguistically diverse cities in Canada with 52 percent of the population speaking a first language other than English.

Vancouver has hosted many international conferences and events, including the 2010 Winter Olympics and 2010 Winter Paralympics.

The International Conference on Annual Clinical Microbiology brings together:

  • Head of Departments
  • Directors/Managers
  • CEO`s of biotech companies
  • Presidents/Vice Presidents
  • Doctors
  • Professors, Associate and Assistant professors
  • Research Scholars and students from the related fields

Scientific Sessions

Annual Clinical Microbiology invites honorable speakers, researcher, PhD. students and exhibitors from all over the world to attend and register for the “8th Annual Congress on Clinical Microbiology” which is going to be organized from December 05-06, 2018 at Vancouver, Canada. We invite you to accompany us at the Annual Clinical Microbiology, where you are assured to have a substantially worthwhile experience with global scholars.

Track 1: Clinical Microbiology and Antimicrobial, Chemotherapy:

Clinical Microbiology conference provides a comprehensive theoretical and practical review of advanced techniques like robotics surgery, sensitive skin, hybridism technology, iris scanning, medical imaging and thermography. Clinical Microbiology is the subject in which any microbes can cause infection in humans. As we know, new microorganisms are being discovered all the time and they are developing more and more resistance to antibiotics, hence microbiologist aims at the application of different microbes for the betterment of human health. Antimicrobial therapy implements the clinical use of antimicrobial agents in treating communicable disease. The positive conclusion of this antimicrobial medical care depends on many factors like website of infection, host defense mechanisms and pharmacokinetic and pharmacodynamics activity of the medication agent. A disinfectant activity depends on the microorganism growth and microorganism division.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

Related Conferences: 8th Annual Congress on Clinical Microbiology, 05-06, December 2017,  Vancouver, Canada; 2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 2nd International congress on Nosocomial and Healthcare Associated Infections,  October 15-16,2018,  Las Vegas, USA; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA.  

 Track 2: Antimicrobial Resistance:

Antimicrobial resistance (AMR) is the capability of a microbe to prevent the effects of medication already used to treat them. Antimicrobial medicines may be sorted in keeping with the microorganisms they act primarily against. As an example, antibiotics are used against bacteria and antifungals are used against fungi. Agents that kill microbes are called microbicidal, whereas those who simply inhibit their growth are called biostatic. Resistance can be present automatically because of accidental mutations; or progressive buildup over time, and because of over usage or misuse of antimicrobials or antibiotics. Resistant microbes are difficult to treat, compelling another medications or higher doses, which may be harmful or costly.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 8th Annual Congress on Clinical Microbiology, 05-06, December 2017,  Vancouver, Canada; 2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 2nd International congress on Nosocomial and Healthcare Associated Infections,  October 15-16,2018,  Las Vegas, USA; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA. 

Track 3: Microbial Pathogenesis:

Microbial Pathogenesis is the study of the molecular mechanisms used by microbes to cause disease in humans and animals. Microbial pathogens incorporate microscopic organisms, infections, growths, and parasites and together record for a huge rate of intense and unending human illnesses. Host-microorganism associations require an interdisciplinary methodology, including microbiology, genomics, informatics, molecular and cell science, natural chemistry, immunology, and the study of disease transmission.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 8th Annual Congress on Clinical Microbiology, 05-06, December 2017,  Vancouver, Canada; 2nd International congress on Nosocomial and Healthcare Associated Infections,  October 15-16,2018,  Las Vegas, USA; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA. 

Track 4: Antimicrobials and Chemotherapy:

An antimicrobial can be described as an agent that kills microorganisms or stops their growth. Antimicrobial medicines can be assembled according to the microorganisms they principally act against. Antibiotics are used against bacteria and antifungals are used against fungi. Antimicrobial chemotherapy implements the clinical use of antimicrobial agents in treating infectious disease. The positive conclusion of this antimicrobial medical aid depends on many factors like site of infection, host defense mechanisms and pharmacokinetic and pharmacodynamics activity of the antibacterial drug agent.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

8th Annual Congress on Clinical Microbiology, 05-06, December 2017,  Vancouver, Canada; 2nd International congress on Nosocomial and Healthcare Associated Infections,  October 15-16,2018,  Las Vegas, USA; 2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA. 

Track 5: Fungal infections:

A branch of biology that concerns with the study of fungi, with their genetic and biochemical properties, their taxonomy and their use to humans as a source of wine, cheese, edible mushrooms and their harmful effects such as toxin or infection. Fungi and other organisms recognized as fungi, such as oomycetes and myxomycetes (slime molds), often are economically essential, as some of them cause diseases in animals such as histoplasmosis. Food spoilage caused by fungi and yeasts can be more significant, particularly in a number of key food groups, those that are acidic in nature or have low moisture content. Mycotoxicology is another branch of mycology that focuses on study of toxins produced by fungi, called as mycotoxins.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA; 8th Annual Congress on Clinical Microbiology, 05-06, December 2017,  Vancouver, Canada; 2nd International congress on Nosocomial and Healthcare Associated Infections,  October 15-16,2018,  Las Vegas, USA; 2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada.

Track 6: Disease, Diagnosis and Prevention:

disease is an abnormal condition, a disorder of a structure or function that affects part or the organism entirely. The study of disease is called pathology which includes the study of cause of the disease. Disease is often construed as a medical condition associated with specific symptoms and signs. Detection of a specific agent for an infection or a health problem is done in clinical presentation.  It may be caused by external factors such as pathogens, or it may be caused by internal dysfunctions particularly of the immune system such as an immunodeficiency, or a hypersensitivity including allergies and autoimmunity.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA.

Track 7: Microbial Infections:

Contamination is the intrusion of a living being's body tissues by ailment causing specialists, their increase, and the response of host tissues to these life forms and the poisons they produce. Diseases are caused by irresistible specialists including infections, viroid’s, prions, microorganisms, nematodes, for example, parasitic roundworm sand pinworms, arthropods, for example, ticks, bugs, insects, and lice, organisms, for example, ringworm, and different macro parasites, for example, tapeworms and different helminthes. A contamination caused by microorganisms. The development of numerous ailment causing microscopic organisms can be stopped by the utilization of anti-toxins

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA; 2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada.

Track 8: Immunity and Vaccination:

The capacity of an organism to resist disease, either through the activities of dedicated blood cells or antibodies produced by them in response to natural exposure or inoculation (active immunity). A vaccine is a product that produces immunity from a disease and can be directed through needle injections, by mouth, or by aerosol.  A vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism. There are vaccines that are administered entirely when the patient has contracted an illness. The intent of such immunizations is to cause an immediate reaction with weakened side-effects.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA; 2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada.

Track 9: Infection Control and Hospital Epidemiology:

Infection control is the discipline concerned with preventing nosocomial or healthcare-associated with infection, a practical (rather than academic) sub-discipline of epidemiology. Anti-infective agents include antibiotics, antibacterial, antifungals, antivirals and antiprotozoal. These are promptly accessible to infections. Infection control and Hospital epidemiology are related to the general public health practice. Infection management contains elements relevant to the spreading of infections; either within the hospitals or alternative aid centers, as well as difficulty via hand hygiene, cleansing or disinfection or sanitization, vaccines or surveillance and probe of infections in a health-care domain. Sterilization kills all microorganisms.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada.

Track 10: Microbial Biofilms:

biofilm is any cluster of microorganisms among that cells persists with one another and sometimes these cells adhere to a surface. These follower cells wind up plainly inserted inside a foul extracellular lattice that is made out of extracellular polymeric substances (EPS). The EPS parts are delivered by the phones inside the biofilm and are normally a polymeric aggregation of extracellular DNA, proteins, and polysaccharides. Because they have three-dimensional structure and speak to a group way of life for microorganisms, biofilms are every now and again depicted allegorically as "urban communities for microbes." A biofilm is a framework that can be adjusted inside to ecological conditions by its occupants. 

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA; 2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada.

Track 11: Microbial biochemistry:

Microbial biochemistry covers the principles and importance of microbes, their growth and their effects on our surroundings and on human health specifically. Microbial biochemistry allowed the formulation of concepts that turned out to be significant in the study of higher organisms. The outline of various layers that enclose the bacterial protoplasm and their role in getting nutrients from the surface media through totally different permeability mechanism are represented. Fundamentals of the mechanisms are how cells get the energy necessary for their growth, mechanisms like, glycolysis, the pentose phosphate pathway etc.

American microbiology Clinical MicrobiologyAnnual Clinical MicrobiologyMicrobial Pathogenesis & Infectious DiseasesDiagnostic Microbiology and Infectious Diseases | Nosocomial and Healthcare Associated Infections

2nd International Conference on Microbial Pathogenesis & Infectious Diseases, June 25-26, 2018 Vancouver, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 3rd International Conference on Diagnostic Microbiology and Infectious Diseases, September 24-25, 2018, Montreal, Quebec, Canada; 7th Annual Conference on  Microbiology September 28-29, 2018,San Antonio, USA.

Market Analysis

The worldwide clinical microbiology advertises is anticipated to achieve USD 5.77 Billion by 2021 from USD 3.35 Billion of every 2016, developing at a CAGR of 11.5% from 2016 to 2021. Market development can be credited to variables, for example, the mechanical progressions; rising rate of irresistible sicknesses and developing flare-up of plagues; developing medicinal services use over the world; and expanding subsidizing, look into awards, and open private interests in the field of life science investigates.

In 2016, North America and Europe are relied upon to be the develop markets for clinical microbiology items. Be that as it may, developing locales, for example, Asia-Pacific (counting Japan, China, and India) are relied upon to end up plainly the new income producing pockets in the market in the following five years. The North American market is relied upon to hold the biggest offer of the worldwide market in 2016. Be that as it may, the Asia-Pacific market is anticipated to develop at the most elevated CAGR amid the conjecture time frame attributable to the developing number of healing facilities and clinical indicative labs in India and China; extending research abilities for the advancement of inventive and reasonable clinical microbiology testing strategies crosswise over India, China, and Japan; and rising occurrences of irresistible ailments.

Europe is relied upon to hold the second-biggest offer of the worldwide clinical microbiology showcase in 2016. This conspicuous market position of the European market is because of components, for example, rising acknowledgment of genome-based analytic methods by human services experts, steady government strategies that simplicity open availability to demonstrative test methodology (counting clinical microbiology), extensive number of clinical microbiology systems performed yearly over the district, nearness of countless and sub-atomic indicative organizations, fast development in the maturing populace, and developing rate of irresistible ailments.

bioMerieux S.A. (France) dominated the global clinical microbiology market in 2015. In the past three years, the company adopted product development and commercialization as its key growth strategies to maintain its dominant position in the global market. Other leading players present in the market include Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.), among others.

 

Past Conference Report

Clinical Microbiology 2017 Report

The 7th Annual Congress on Clinical Microbiology, hosted by Committee Annual Clinical Microbiology 2017 was successfully held during September 25-26, 2017 in Chicago, USA. The conference highlighted the theme “Advances in Infectious Diseases and future trends in Clinical Microbiology”. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by Committee Annual Clinical Microbiology 2017 received a generous response from the Editorial Board Members of Committee Annual Clinical Microbiology 2017 Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2016 from Committee Annual Clinical Microbiology 2017. The conference was marked by the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the two-day event into the path of success with thought-provoking keynote and plenary presentations.

The highlights of the meeting where the keynote lectures from

•             Stef Stienstra, Armed Forces of Netherlands, Netherlands

•             Paul Kadetz, Drew University, United States

•             Christine I Wooddell, Arrowhead Pharmaceuticals, United States

•             Lia Monica Junie, University of Medicine and Pharmacy, Romania

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Moderator Dr. Stef Stienstra, Armed Forces of Netherlands, Netherlands. For his remarkable contribution towards smooth functioning at Annual Clinical Microbiology 2017. The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Annual Clinical Microbiology 2017 with the sessions include Microbial Biofilms | Nosocomial Infections | Host Pathogens Interaction | Infection Novel Therapies | Health Science | Clinical Virology | Disease, Diagnosis and Prevention | Antimicrobial Resistance| Microbial Pathogenesis | Infection Control and Hospital Epidemiology | Microbial Infections | Medical Microbiology | Immunity and Vaccination

To share your views and research, please click here to register for the Annual Clinical Microbiology 2018 Conference.

The Committee Clinical Microbiology 2017 would like to convey a warm gratitude to all Honorable Guests and Keynote Speakers of Annual Clinical Microbiology 2017 Conference.

Clinical Microbiology 2017 Conference witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Clinical Microbiology. The event enlightened various areas of genomics in different fields with plenary lectures from the speakers of various universities and organizations like

•            Barley Chironda, Toronto East General hospital, Canada

•            Al dubisi Fatimah, University of Toronto, Canada

•            Dhruv K. Mamtora, S. L. Raheja Hospital, India

•            Hafid Soualhine, National Public Health Institute of Quebec, Canada

•            Shirley Gutkowski, Primal Air LLC, USA

•            Ibrahim Zeid, Hammoud, Hospital University, Lebanon

            Mohamed A Abouelkhair, University of Tennessee, USA    

     

We are obliged to various delegate experts, institutes and other eminent personalities who actively took part in the discussion and meetings. We sincerely thank the Organizing Committee Members for their gracious presence and continuous support towards the success of Annual Clinical Microbiology 2017 Conference.

With the valuable feedback and generous response received from the participants of the event.

The committee Clinical Microbiology would like to announce the commencement of the 8th Annual Congress on Clinical Microbiology and Infectious Diseases December 05-06, 2018 in Vancouver, Canada.

 

 

Contact us for more queries…!!!!

Clinical Microbiology & Infections 2018

Carole Smith

[email protected]

702-508-5200 Ext : 8038

To Collaborate Scientific Professionals around the World

Conference Date December 05-06, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Clinical Microbiology: Open Access

Journal of Medical Microbiology & Diagnosis

Journal of Infectious Diseases & Therapy

Air & Water Borne Diseases

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by